Parkinson's disease: clinical aspects - PubMed (original) (raw)

Review

. 2004 Oct;318(1):115-20.

doi: 10.1007/s00441-004-0975-6. Epub 2004 Sep 8.

Affiliations

• PMID: 15365814
• DOI: 10.1007/s00441-004-0975-6

Review

Parkinson's disease: clinical aspects

Thomas Klockgether. Cell Tissue Res. 2004 Oct.

Abstract

Parkinsonism is a clinical syndrome characterized by akinesia, muscular rigidity, and resting tremor. The most frequent cause of parkinsonism is Parkinson's disease (PD). Progressive loss of substantia nigra neurons together with the occurrence of Lewy bodies are considered essential neuropathological features of PD. Recent neuropathological studies suggest that nigral degeneration is only part of a more extended brain degeneration that starts in the medulla oblongata and then spreads to the mesencephalon and cerebral cortex. Correspondingly, the clinical symptoms occurring in PD go far beyond parkinsonism. Depending on the disease stage, autonomic dysfunction, olfactory disturbances, depression, and dementia are frequently encountered in PD. These neuropathological and clinical observations have major implications for future research in PD. In particular, the analysis of the properties that the neuronal cell types involved in PD have in common and that might make them susceptible to degeneration is essential.

PubMed Disclaimer

Similar articles

• Variability in the clinical expression of Parkinson's disease.
  Wolters ECh. Wolters ECh. J Neurol Sci. 2008 Mar 15;266(1-2):197-203. doi: 10.1016/j.jns.2007.08.016. Epub 2007 Sep 12. J Neurol Sci. 2008. PMID: 17854836 Review.
• Parkinson's disease: premotor clinico-pathological correlations.
  Wolters ECh, Braak H. Wolters ECh, et al. J Neural Transm Suppl. 2006;(70):309-19. doi: 10.1007/978-3-211-45295-0_47. J Neural Transm Suppl. 2006. PMID: 17017546 Review.
• [Nosological correlation between autonomic failure with Lewy bodies and Parkinson's disease--comparative assessment of clinical features in both diseases].
  Tamura N, Shimazu K, Yamamoto T, Watanabe S, Hamaguchi K. Tamura N, et al. Rinsho Shinkeigaku. 1990 Nov;30(11):1208-13. Rinsho Shinkeigaku. 1990. PMID: 2085926 Japanese.
• Research in motion: the enigma of Parkinson's disease pathology spread.
  Brundin P, Li JY, Holton JL, Lindvall O, Revesz T. Brundin P, et al. Nat Rev Neurosci. 2008 Oct;9(10):741-5. doi: 10.1038/nrn2477. Epub 2008 Sep 4. Nat Rev Neurosci. 2008. PMID: 18769444 Review.

Cited by

• Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice.
  Yang P, Arnold SA, Habas A, Hetman M, Hagg T. Yang P, et al. J Neurosci. 2008 Feb 27;28(9):2231-41. doi: 10.1523/JNEUROSCI.3574-07.2008. J Neurosci. 2008. PMID: 18305256 Free PMC article.
• mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson's Disease.
  Farmer K, Abd-Elrahman KS, Derksen A, Rowe EM, Thompson AM, Rudyk CA, Prowse NA, Dwyer Z, Bureau SC, Fortin T, Ferguson SSG, Hayley S. Farmer K, et al. Mol Neurobiol. 2020 Mar;57(3):1418-1431. doi: 10.1007/s12035-019-01818-z. Epub 2019 Nov 21. Mol Neurobiol. 2020. PMID: 31754998
• Searching for Potential Lipid Biomarkers of Parkinson's Disease in Parkin-Mutant Human Skin Fibroblasts by HILIC-ESI-MS/MS: Preliminary Findings.
  Calvano CD, Ventura G, Sardanelli AMM, Savino L, Losito I, Michele G, Palmisano F, Cataldi TRI. Calvano CD, et al. Int J Mol Sci. 2019 Jul 7;20(13):3341. doi: 10.3390/ijms20133341. Int J Mol Sci. 2019. PMID: 31284683 Free PMC article.
• 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous neurotoxic compound, disturbs the behavioral and biochemical effects of L-DOPA: in vivo and ex vivo studies in the rat.
  Wąsik A, Romańska I, Michaluk J, Kajta M, Antkiewicz-Michaluk L. Wąsik A, et al. Neurotox Res. 2014 Oct;26(3):240-54. doi: 10.1007/s12640-014-9476-x. Epub 2014 May 20. Neurotox Res. 2014. PMID: 24842650 Free PMC article.
• Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression.
  Leão AH, Meurer YS, da Silva AF, Medeiros AM, Campêlo CL, Abílio VC, Engelberth RC, Cavalcante JS, Izídio GS, Ribeiro AM, Silva RH. Leão AH, et al. Front Aging Neurosci. 2017 Mar 27;9:78. doi: 10.3389/fnagi.2017.00078. eCollection 2017. Front Aging Neurosci. 2017. PMID: 28396635 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information